A clinical research study is being conducted to see if an investigation drug could be safe and effective in impacting the symptoms of Polycystic Ovarian Syndrome (PCOS). This study is being conducted by Angelina Gangestad, MD at University Hospitals Landerbrook Health Center.
If you are a woman between the ages of 18 and 35 with PCOS you may qualify for this study.
If you are eligible and participate in this research study, you may receive compensation for your time and travel.
To learn more about this research study and to see if you qualify, please contact the MacDonald Clinical Research Unit referral line: 440-995-3810 or email: MCTU@uhhospitals.org